×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 9 Track 3: Field Medical and Engagement with Payers
Session Chair(s)
Iris Tam, PharmD
Senior Vice President and Head, Medical Affairs and HEOR
COEUS, United States
This session will provide an overview of the key involvement and activities that field teams engage in with payers.
Learning Objective : - List 3 tools that are developed by Medical Affairs for payers
- Describe 2 key topics or activities that are important for field medical to engage in or support for payers during the pre-approval period of a pipeline product
- Describe 2 key topics or activities that are important for field medical to engage in or support for payers during the launch of a new product
Speaker(s)
Engaging with Payers During the Pre-Approval Period
Patricia Bourne, PharmD
Cytokinetics, United States
Senior Director, Medical Sciences
Engaging with Payers During Product Launch
Representative Invited
BeiGene, United States
Field Payer Engagement: Large BioPharma Perspective
Stuart O’Brochta, PharmD
Gilead, United States
Executive Medical Value and Evidence Liasion, US Medical Affairs